期刊文献+

胸腔镜下肺癌根治术患者围术期血清CEA、CA125、CY211、EGF及红细胞免疫功能水平的变化研究 被引量:8

Change of serum CEA,CA125,CY211,EGF and erythrocyte immune function of patients treated with thoracoscopic pulmonary carcinoma radical resection during perioperative period
下载PDF
导出
摘要 目的:分析研究胸腔镜下肺癌根治术患者围术期血清癌胚抗原(CEA)、糖类抗原125(CA125)、细胞角蛋白19片段(CY211)、表皮生长因子(EGF)及红细胞免疫功能的变化情况。方法:选取于本院采用开胸手术进行治疗的32例肺癌患者为对照组,并将同时期采用胸腔镜根治性手术进行治疗的32例患者设为观察组,然后将两组患者手术前1d与手术后3、7d的血清CEA、CA125、CY211、EGF水平和阳性率、红细胞免疫功能指标水平进行比较。结果:观察组与对照组手术后3、7d的血清CEA、CA125、CY211水平和阳性率比较,差异具有统计学意义(P>0.05);而术后均低于术前,EGF水平和阳性率均低于对照组,红细胞免疫功能指标则均明显优于对照组,差异均具有统计学意义(P<0.05)。结论:胸腔镜下肺癌根治术患者围术期血清CEA、CA125、CY211、EGF及红细胞免疫功能的变化较为明显,既达到了有效治疗疾病的目的,又降低了对机体免疫功能的不良影响。 Objective. To study the change of serum CEA, CA125, CY211, EGF and erythrocyte immune function of patients treated with thoracoscopic pulmonary carcinoma radical resection during peri- operative period. Methods. A total of 32 patients with pulmonary carcinoma and treated with open-chest operation in our hospital from April 2011 to February 2013 were selected as control group, 32 patients trea- ted with thoracoscopic radical resection at the same time as the observation group, then the levels and posi- tive rate of serum CEA,CA125,CY211,EGF and erythrocyte immune function indexes of two groups on the 1st day before the operation and on the 3rd,7th day after the operation were compared. Results:Levelsand positive rate of serum CEA, CA125, CY211 of observation group had no significant differences from control group (P〉0.05) while those indexes after the operation were all lower than those before the oper- ation,the levels and positive rate of EGF were all lower than those of control group,erythrocyte immune function indexes were all significantly better than those of control group (all P〈0.05). Conclusions: Change of serum CEA, CA125, CY211, EGF and erythrocyte immune function of patients treated with tho- racoscopic pulmonary carcinoma radical resection during perioperative period is significant. Thoracoscopic pulmonary carcinoma radical resection can decrease side effect on the immune function.
作者 刘涌
出处 《海南医学院学报》 CAS 2013年第8期1080-1083,共4页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210747)~~
  • 相关文献

参考文献10

二级参考文献90

  • 1时广利,胡秀玲,岳思东,宋长兴.血清肿瘤标志物在肺癌辅助诊断中的应用[J].中华肿瘤杂志,2005,27(5):299-301. 被引量:82
  • 2Robert J. McKenna,罗晓阳.肺癌微创治疗新技术现状——胸腔镜在肺癌治疗中的应用[J].中国癌症杂志,2005,15(3):209-212. 被引量:59
  • 3万锦平,黄建安,刘皓,张秋娣.血清SCC-Ag、CYFRA21-1、NSE、CEA联合检测对肺癌的诊断价值[J].临床肺科杂志,2007,12(2):111-112. 被引量:54
  • 4Waller DA. Surgery for non-small cell lung cancer-new trends [ J ] . Lung Cancer, 2001, 34 (Suppl 2): 133-136.
  • 5Landreneau R J, Pigula F, Luketich JD, et al. Acute and chronic morbidity differences between Muscle-Sparing and standard lateral thoracotomies [ J ] . Thorac Cardiovasc Surg, 1996, 112(5): 1346-50; discussion: 1350-1351.
  • 6Akcali Y, Demir H, Tezcan B. The effect of standard posterolateral verses Muscle-Sparing thoracotomy on multiple parameters [ J ] . Ann Thorac Surg, 2003, 76(4): 1050-1054.
  • 7Benedetti F, Vighetti S, Ricco C, et al. Neurophysiologic assessment of nerve impairment in posterolateral and Muscle- Sparing thoracotomy [ J ] . J Thorac Cardiovasc Surg, 1998, 115(4): 841-847.
  • 8Bethencourt DM, Holmes EC. Muscle-Sparing posterolateral thoracotomy [ J ] . Ann Thorac Surg, 1988, 45(3): 337-339.
  • 9Kutlu CA, Akin H, Olcmen A, et al. Shoulder-girdle strength after standard and lateral Muscle-Sparing thoracotomy[J].Thoarc Cardiovasc Surg, 2001, 49(2): 112-114.
  • 10Yano S, Nishioka Y, Izumi K, et al. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells [J].Int J Cancer, 1996, 67(2): 211-217.

共引文献80

同被引文献79

  • 1Nakano S, Gibo J, Fukushima Y, et al. Perfusion evaluation of lung cancer: assessment using dual input perfusion computed tomography[J]. J Thorac Imaging, 2013,28(4) : 253-262.
  • 2Eisenhauer EA, Therasse P, Boqaerts J, et al. New response e- valuation criteria in solid tumours., revised RECIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2) :228-247.
  • 3Koyama J, Honio S, Morizono R, et al. Hepatocellular carcinoma with multiple lung metastasis resulting in long-term disease-free survival by transcateter arterial infusion chemotherapy of SMANCS[J]. Gan To Kagaku Ryoho, 2011, 38(3) : 461-464.
  • 4Guzinska-Ustymowicz K, Pryczynicz A, Kemona A, et al. Im- munohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region oftumor and me- tastases of colorectal caneer[J]. Adv Med, 2011,56(1) :39-43.
  • 5Schiffman SC, Metzger T, Dubel G, et al. Central type lung cancer: Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carci- noma: optimal tolerance and prolonged overall survival[J]. Ann Surg Oncol, 2011,18(2) :431-438.
  • 6Gossot D,Zaimi R,Fournel L. Totally thoraco scopic pulmonary anatomic segmentectomies:technical considerations[J].J Thorac Dis,2013,(3):200-206.
  • 7路丽娜,曹爱国.用图像引导放射技术对肺癌患者进行放射治疗的效果探讨.医学信息,2015(45):243-245.
  • 8欧阳军.加替沙星注射液应用在肺癌术后合并肺部感染中的临床效果.医学信息,2015(38):145-146.
  • 9毛正道,韦国桢,殷小伟.探讨肿瘤标记物CY211、NSE、CEA及CA125在肺癌诊断中的意义[J].实用临床医药杂志,2010,14(2):18-21. 被引量:23
  • 10谢咏秋,焦赫娜,郭曲练,陈婵.依托咪酯诱导与维持麻醉对肺癌根治术患者血清皮质醇含量的影响[J].南方医科大学学报,2010,30(5):1047-1049. 被引量:7

引证文献8

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部